Quality & complianceOfficial

FDA lists Class II recall of Advagen's metoprolol tartrate tablets over foreign tablets or capsules

🇺🇸 FDA enforcement report · Wed 11 Nov 2026

The US enforcement report records an ongoing, nationwide recall of Advagen Pharma Limited's metoprolol tartrate tablets, citing the presence of foreign tablets or capsules.

The US Food and Drug Administration has published an entry in its enforcement report for a Class II recall of Metoprolol Tartrate Tablets made by Advagen Pharma Limited. The recall number is D-0182-2027, and the report is dated 11 November 2026.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: FDA enforcement report ↗

Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.